. Effect of acute exercise on uncoupling protein 3 is a fat metabolism-mediated effect. Am J Physiol Endocrinol Metab 282: E11-E17, 2002.-Human and rodent uncoupling protein (UCP)3 mRNA is upregulated after acute exercise. Moreover, exercise increases plasma levels of free fatty acid (FFA), which are also known to upregulate UCP3. We investigated whether the upregulation of UCP3 after exercise is an effect of exercise per se or an effect of FFA levels or substrate oxidation. Seven healthy untrained men [age: 22.7 Ϯ 0.6 yr; body mass index: 23.8 Ϯ 1.0 kg/m 2 ; maximal O2 uptake (V O2 max): 3,852 Ϯ 211 ml/min] exercised at 50% V O2 max for 2 h and then rested for 4 h. Muscle biopsies and blood samples were taken before and immediately after 2 h of exercise and 1 and 4 h in the postexercise period. To modulate plasma FFA levels and fat/glucose oxidation, the experiment was performed two times, one time with glucose ingestion and one time while fasting. UCP3 mRNA and UCP3 protein were determined by RT-competitive PCR and Western blot. In the fasted state, plasma FFA levels significantly increased (P Ͻ 0.0001) during exercise (293 Ϯ 25 vs. 1,050 Ϯ 127 mol/l), whereas they were unchanged after glucose ingestion (335 Ϯ 54 vs. 392 Ϯ 74 mol/l). Also, fat oxidation was higher after fasting (P Ͻ 0.05), whereas glucose oxidation was higher after glucose ingestion (P Ͻ 0.05). In the fasted state, UCP3L mRNA expression was increased significantly (P Ͻ 0.05) 4 h after exercise (4.6 Ϯ 1.2 vs. 9.6 Ϯ 3.3 amol/g RNA). This increase in UCP3L mRNA expression was prevented by glucose ingestion. Acute exercise had no effect on UCP3 protein levels. In conclusion, we found that acute exercise had no direct effect on UCP3 mRNA expression. Abolishing the commonly observed increase in plasma FFA levels and/or fatty acid oxidation during and after exercise prevents the upregulation of UCP3 after acute exercise. Therefore, the previously observed increase in UCP3 expression appears to be an effect of prolonged elevation of plasma FFA levels and/or increased fatty acid oxidation. fat oxidation; uncoupling protein; fatty acids; mitochondria THE HUMAN UNCOUPLING PROTEIN (UCP) 3 uncouples the respiratory chain, producing heat without an increase in ATP production, and is therefore suggested to play a role in human energy metabolism, obesity, and diabetes (30). We have previously shown a positive correlation between metabolic rate and UCP3 mRNA expression in humans (31), although results are conflicting (2). Furthermore, mice overexpressing UCP3 in skeletal muscle are hyperphagic but weigh less than control mice (7). These data indicate that UCP3 could indeed play an important role in thermogenesis; however, several findings regarding the regulation of UCPs do not match with a role for UCP3 in energy metabolism. For example, UCP3 mRNA expression is upregulated during fasting, both in rodents (35) and in humans (19), whereas in a situation of food deprivation conservation of energy is observed (14). An explanation for the unexpected upregulation of UCP3 during fasting comes from the observation that free fatty acids (FFA) upregulate UCP3 mRNA expression both in rodents (35) and in humans (15). During fasting and situations of elevated plasma FFA levels, fat oxidation is also increased, and it has been suggested that UCP3 is involved in the handling of lipids as a fuel (25).
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During and after acute endurance exercise, energy expenditure, plasma FFA levels, and substrate oxidation are increased rapidly. The effect of acute endurance exercise on UCP3 mRNA expression has been studied in rodents, showing a rapid upregulation of UCP3 mRNA postexercise (9, 32, 36) . In humans, few data are available regarding the effect of acute exercise on UCP3 mRNA expression. We previously measured UCP3 mRNA expression before and immediately after 80 min of exhaustive cycling exercise and did not observe an effect of acute exercise on UCP3 mRNA (29) . Pilegaard et al. (23) observed that UCP3 mRNA was upregulated 1-4 h after an acute bout of exercise. However, none of the studies mentioned above have addressed the possible effect of plasma FFA levels on UCP3 expression during exercise. Because high plasma FFA levels are associated with an upregulation of UCP3 mRNA and exercise is characterized by an increased level of plasma FFA, it is very well possible that the exercise-induced upregulation of UCP3 is not an exercise effect but an FFA-mediated effect. Therefore, the aim of the present study was to examine whether the upregulation of UCP3 mRNA expression after acute exercise is an effect of exercise per se or an effect of increased levels of plasma FFA. For this, UCP3 mRNA expression was measured immediately after as well as 1 and 4 h after a 2-h exercise bout, which was performed one time without and one time with glucose ingestion. We have previously shown that glucose ingestion results in a marked reduction in FFA availability and fatty acid oxidation and a marked increase in plasma glucose levels and glucose oxidation (10) . Because no data are available on the effect of exercise on UCP3 protein content, we also determined the latter in the present study.
METHODS

Subjects
Seven healthy, untrained male volunteers participated in this study. Subject characteristics are shown in Table 1 . None of the subjects participated in endurance sports, but all were moderately active. The nature and risks of the experimental procedure were explained to the subjects, and all subjects gave their written informed consent. The study was approved by the Medical-Ethical Committee of Maastricht University.
Experimental Design
After an overnight fast, subjects came to the laboratory at 8:00 AM, and a percutaneous muscle biopsy was taken from the vastus lateralis muscle. After local anesthesia, a 5-mmdiameter side-cutting needle was passed through a 7-mm skin incision. The muscle biopsy was frozen immediately in liquid nitrogen and stored at Ϫ80°C until assayed. After this, a Teflon cannula was inserted in an antecubital vein for sampling of blood. Subjects rested on a bed, and a baseline blood sample was taken [baseline, time (t) ϭ Ϫ60 min]. Immediately after the first blood sample was taken, subjects ingested 1.4 g/kg body wt glucose (dissolved in water to a 20% solution and flavored with 1 ml lemon juice). At t ϭ Ϫ10, 30, 60, 90, 180, 240, and 300 min, subjects ingested 0.35 g/kg body wt glucose (dissolved in water to a 10% solution and flavored with 1 ml lemon juice).
After having rested for 1 h, subjects started exercising at 50% of maximal power output (W max; t ϭ 0 min). The exercise bout lasted for 2 h, and during exercise blood samples were taken every 30 min (at t ϭ 30, 60, 90, and 120 min). Immediately after cessation of the 2 h of exercise, a second muscle biopsy was taken (t ϭ 120 min). After the muscle biopsy was taken, subjects rested on a bed for 4 h, and a third and fourth muscle biopsy was taken after 1 (t ϭ 180 min) and 4 (t ϭ 360 min) h of rest. During this postexercise period, blood samples were taken every hour (at t ϭ 180, 240, 300, and 360 min). The experimental design is depicted in Fig. 1 .
Indirect calorimetry was performed continuously at rest and in the last 10 min of every half-hour during exercise. The entire protocol was repeated after at least 1 wk but now with ingestion of equal amounts of water. Subjects started at random with either the water or the glucose trial.
Procedures
Maximal power output. Before the experiment (1 wk), each subject performed an incremental exercise test on an electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, The Netherlands) to determine maximal oxygen consumption. Exercise was performed until voluntary exhaustion or until the subject could no longer maintain a pedaling rate of Ն60 rpm. Oxygen consumption (V O2) and carbon dioxide production (V CO2) were measured using open circuit spirometry (Oxycon-␤, Mijnhard, The Netherlands).
Muscle biopsy, UCP3 mRNA expression, and UCP3 protein content. Muscle biopsies were taken from the midthigh region from the vastus lateralis muscle according to the technique of Bergström et al. (3) . Part of the biopsy was used for isolation of total RNA using the acid phenol method of Chomczynski and Sacchi (6) , with an additional DNase digestion step with concomitant acid-phenol extraction and ethanol precipitation. UCP3L (390-nt-long) and UCP3S (436-nt-long) cDNA fragments were obtained by RT-PCR. The two competitor DNAs were obtained by a deletion of 40 bp (20) . For the assay, the RT reaction was performed from 0.2 g of skeletal muscle total RNA in the presence of a thermostable reverse transcription (Promega) by use of one of the specific antisense primers. The competitive PCR assays were performed as previously described (19, 20) . To improve the quantification of the amplified products, fluorescent dye-labeled sense oligonucleotides were used. The PCR products were separated and analyzed on an ALFexpress DNA sequencer (Pharmacia) with the Fragment Manager Software. Total RNA preparations and RT-competitive PCR assays of the skeletal muscle samples from the same individual (before Ϫ after acute exercise) were performed simultaneously.
The remaining part of the muscle biopsies was homogenized in ice-cold Tris-EDTA buffer at pH 7.4; thereafter, the homogenates were sonicated for 3 ϫ 5 s. Subsequently, 2 vol of each skeletal muscle homogenate and 1 vol of SDS sample buffer were boiled for 4 min (17) . Polyacrylamide gels (12%) containing 0.1% SDS were loaded with equal amounts of protein of each sample, and electrophoresis was performed BMI, body mass index; V O2max, maximal O2 uptake; Wmax, maximal power output. http://ajpendo.physiology.org/ using a Mini-Protean 3 Electrophoresis Cell (Bio-Rad Laboratories, Hercules, CA), followed by Western blotting using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Laboratories). The separated polypeptides were transferred to a nitrocellulose membrane (0.45 m; Bio-Rad Laboratories) by blotting for 1 h at 100 V in a cold (4°C) buffer containing 25 mM Tris, 192 mM glycine, and 20% methanol.
After protein transfer, nitrocellulose sheets were blocked with 5% nonfat dry milk in 0.05% Tween 20-PBS; thereafter, antibody incubation was performed by gentle shaking overnight at room temperature at a dilution of 1:5,000 in 5% nonfat dry milk in 0.05% Tween 20-PBS. A rabbit polyclonal UCP3 antibody (code:1331, kindly provided from L. J. Slieker, Eli Lilly) prepared against a 20-amino acid peptide (human sequence amino acids 147-166) that recognizes both the long and the short form of UCP3 and previously was shown not to recognize UCP2 was used (12) . The antibody was affinity purified on a Sulfolink column (Pierce, Omnilabo International, Breda, The Netherlands) containing the peptide coupled through a COOH-terminal Cys. Cross-reaction of the antibody with other proteins was checked for by examining the entire 5-to 94-kDa range for additional bands. The molecular mass of the band visualized by chemiluminescence was compared with reference values.
After antibody incubation, the blots were incubated for 60 min with horseradish peroxidase-conjugated swine anti-rabbit Ig (Dako) at a dilution of 1:10,000. The blots were washed for 2 h in 0.05% Tween 20-PBS and treated for 1 min with chemiluminescence substrate (Super Signal West Dura Extended Duration Substrate; Pierce). Finally, a clear blue X-ray film (CL-Xposure Film; Pierce) was exposed to the nitrocellulose sheets for 1 min. The reaction product of each blot was analyzed by densitometry using Imagemaster (Pharmacia Biotech).
Blood Analysis
Blood was collected in tubes containing EDTA to prevent clotting and immediately centrifuged at 4,000 rpm for 10 min at 4°C. Plasma was frozen in liquid nitrogen and stored at Ϫ80°C. Plasma substrates were determined using the hexokinase method (Roche, Basel, Switzerland) for glucose and the Wako NEFA C test kit (Wako Chemicals, Neuss, Germany) for FFA.
Calculations
From the recorded V O2 and V CO2 (Oxycon-␤), carbohydrate and fat oxidation rates and energy expenditure were calculated using the formulas of Péronnet and Masssicotte (22) .
Statistical Analysis
Repeated-measures ANOVA was performed to examine differences in measured parameters between the glucose and fasted treatment at any time point. Two-way ANOVA was performed to examine interaction between time and treatments. For comparing overall differences between treatments, areas under the curve were calculated for t ϭ 30 to t ϭ 120 min during exercise and for t ϭ 180 to t ϭ 360 min postexercise. Pearson correlation coefficients were calculated to determine the relationship between selected variables. All data are presented as means Ϯ SE, and a P value Ͻ0.05 was considered statistically significant.
RESULTS
Energy Expenditure and Substrate Oxidation
There were no significant differences in energy expenditure between the glucose treatment and the fasted state at baseline, during exercise, or postexercise ( Table 2 ).
The respiratory quotient was significantly higher (P Ͻ 0.05) at every time point with the glucose treatment compared with the fasted state (Fig. 2) . The area under the respiratory quotient vs. time curve was significantly higher with the glucose treatment compared with the fasted state during both exercise and postexercise (P Ͻ 0.05). Carbohydrate oxidation was significantly higher (P Ͻ 0.05) and fat oxidation was significantly lower (P Ͻ 0.05) at every time point with the glucose treatment compared with the fasted state (Table 2). During exercise, fat oxidation increased between t ϭ 30 and t ϭ 120 min in both conditions (P Ͻ 0.001), but there was no time vs. treatment interaction. Carbohydrate oxidation decreased between t ϭ 30 and t ϭ 120 min with the glucose treatment (P Ͻ 0.05), whereas this decrease between t ϭ 30 and t ϭ 120 min in the fasted state was almost significant ( Table 2 , P ϭ 0.06). In both conditions, carbohydrate and fat oxidation reached a steady state postexercise. The area under the carbohydrate oxidation vs. time curve was significantly higher with the glucose treatment compared with the fasted state during both exercise and postexercise (P Ͻ 0.05), whereas the area under the fat oxidation vs. time curve was lower with the glucose treatment compared with the fasted state (P Ͻ 0.05). 
Blood Analysis
Plasma FFA concentration (Fig. 3A) was significantly lower at every time point with the glucose treatment compared with the fasted state (P Ͻ 0.05). During exercise, plasma FFA concentration gradually increased in the fasted state (P Ͻ 0.0001), whereas in the glucose treatment an initial decline in plasma FFA levels was present (319 Ϯ 19 vs. 135 Ϯ 13 at baseline and t ϭ 30 min, respectively, P Ͻ 0.05). After the initial decline, plasma FFA levels also gradually increased with the glucose treatment (P Ͻ 0.001). There was a significant time vs. treatment interaction (P Ͻ 0.0001), indicating that plasma FFA levels increased significantly more in the fasted state compared with the glucose treatment during exercise. Postexercise plasma FFA levels were in a steady state in both conditions. The area under the plasma FFA level vs. time curve was significantly higher during both exercise and postexercise in the fasted state compared with the glucose treatment. Plasma glucose concentration (Fig. 3B ) was significantly higher during exercise at t ϭ 90 and 120 min and 1 (t ϭ 180 min) and 4 (t ϭ 360 min) h postexercise (P Ͻ 0.05) with the glucose treatment compared with the fasted state. During exercise, plasma glucose concentration gradually decreased in the fasted state (P Ͻ 0.0001), whereas with the glucose treatment plasma glucose levels significantly increased between t ϭ 30 and t ϭ 120 min (P Ͻ 0.001). There was a significant time vs. treatment interaction (P Ͻ 0.0001). Postexercise plasma glucose levels were in a steady state in the fasted state, whereas with the glucose treatment plasma glucose was decreased 3 h postexercise (at t ϭ 300 min) compared with 1 h postexercise (t ϭ 180 min, P ϭ 0.03). During both exercise and postexercise, the area under the plasma glucose levels vs. time curve tended to be significantly higher with the glucose treatment compared with the fasted state (P ϭ 0.055).
Effect of Acute Exercise on UCP3 mRNA and UCP3 Protein Content
At baseline, UCP3 mRNA expression and UCP3 protein content were not significantly different between the glucose treatment and fasted state. Acute exercise had no immediate effect on UCP3L mRNA expression. However, in the fasted state, UCP3L mRNA expression was increased significantly with, on average, ϳ106% 4 h postexercise (t ϭ 360 min) compared with baseline, immediately after exercise (t ϭ 120 min), and 1 h postexercise (t ϭ 180 min; P Ͻ 0.05, Fig. 4 ). With the glucose treatment, no differences in UCP3L mRNA expression were observed (P ϭ 0.43). UCP3L mRNA expression tended to be higher in the fasted state compared with glucose treatment 4 h postexercise (at t ϭ 360 min, P ϭ 0.07). No differences in UCP3S mRNA expression between conditions and/or time points were observed (Table 3) . UCP3 protein content did not change significantly during or after exercise in any of the conditions and was not significantly different between the glucose treatment and fasted state at any time point measured (Table 3) .
DISCUSSION
Acute exercise has been shown to result in an upregulation of UCP3 mRNA expression (9, 23, 32, 36) . Acute exercise also results in an increase in plasma FFA levels, and it has been shown that FFA upregulate UCP3 mRNA expression (15, 35) . In the present study, we examined the effect of 2 h of moderate-intensity exercise on UCP3 mRNA in two different situations (with high and low plasma FFA levels). The data show clearly that this exercise regime resulted in an upregulation of UCP3L mRNA, but only when plasma FFA were elevated for several hours. Acute exercise without elevation of plasma FFA levels, but with high plasma glucose levels and glucose oxidation, does not lead to significant changes in UCP3L mRNA expression in muscle. The short isoform of UCP3, which lacks the last coding exon, was not upregulated in either treatment. UCP3S mRNA likely results in a truncated protein, lacking the sixth transmembrane domain (4) and possibly leading to altered uncoupling activity. However, the precise function of the two isoforms is presently unknown. Furthermore, the upregulation of UCP3L mRNA was not accompanied by changes in UCP3 protein content over this 4-h postexercise period, suggesting that the translation of UCP3 mRNA into protein requires more than these 4 h. This is not surprising when it is considered that the half-life of UCP1 protein, a mitochondrial protein with high homology to UCP3, is ϳ5 days, which would indicate that several days are needed for changes in mRNA to become evident as changes in protein (21) . Taken together, our results show that the effect of a 2-h exercise bout of moderate intensity on UCP3L mRNA is not an exercise effect per se but rather a fat metabolismmediated effect.
The function of human UCP3 is presently unknown. Because UCP3 is expressed specifically in skeletal muscle in humans (4) and because skeletal muscle is known to be an important thermogenic organ (1), UCP3 has been considered to be involved in human energy metabolism. Acute exercise is characterized by marked increases in energy expenditure, both during and after the exercise bout. Therefore, the effect of acute exercise on UCP3 expression has been investigated previously. Zhou et al. (36) showed that UCP3 mRNA expression was upregulated sevenfold after 30 min of treadmill running in rats. Similarly, Cortright et al. (9) observed that, after 1 h of treadmill running, UCP3 mRNA expression was elevated 63 and 252% in red and white gastrocnemius muscle, respectively. Tsuboyama-Kasaoka et al. (32) showed that UCP3 mRNA levels in rats were upregulated 3 h after 1 h of swimming but returned to baseline 22 h postexercise. In humans, Pilegaard et al. (23) showed that UCP3 mRNA was upregulated 4 h after acute exercise. These data are consistent with a role for UCP3 in the regulation of energy metabolism. However, there are also data that seem to be incompatible with the concept of energy dissipation. For example, UCP3 expression in skeletal muscle is increased during fasting (19, 24) , an energy turnover-attenuating condition. Because UCP3 also increases upon high-fat feeding (35) and fasting results in elevated levels of plasma FFA levels, it has been suggested that changes in fatty acid metabolism are responsible for the increased UCP3 expression during fasting and high-fat feeding. According to some theories, the uncoupling function of UCP3 involves the outward transport of fatty acid anions across the inner mitochondrial membrane (13) . This also suggests that it is not necessarily the amount of plasma FFA that determines the expression of UCP3 but rather the delivery of fatty acids to the mitochondria or the concentration of fatty acids inside the mitochondria. In- hibiting fatty acid oxidation by administration of etomoxir, a blocker of carnitine palmitoyltransferase I (the rate-limiting enzyme for uptake of fatty acids by the mitochondria), results in a decrease in UCP3 mRNA expression, even though plasma FFA levels are high (25) . This suggests that UCP3 expression could be related to fatty acid oxidation. Further evidence for the latter comes from our recent finding (27) that UCP3 mRNA expression was upregulated after consumption of a high-fat diet for 4 wk, which is known to result in an increase in fatty acid oxidation, whereas plasma FFA levels are known to be unaltered after long-term high-fat diets (26, 27) .
Because acute exercise not only results in an increase in energy expenditure but also increases plasma FFA levels and fat oxidation, we examined in the present study whether the increase in UCP3 mRNA after acute exercise could be more directly related to changes in fat metabolism instead of to changes in energy metabolism. We found that the effect of 2 h of moderate-intensity exercise on UCP3 mRNA expression is not a direct effect of exercise per se but rather an effect of sustained elevated plasma FFA levels and/or increased fatty acid oxidation. Because there was no difference in energy expenditure between the fasted and glucose treatments, the results show that the upregulation of UCP3L after exercise does not seem to be related to exercise-induced changes in energy metabolism. This might indicate, but does not necessarily prove, that the primary function of skeletal muscle UCP3 during exercise is not related to the regulation of energy metabolism. Alternatively, UCP3 might play a role in fatty acid metabolism. We recently postulated a hypothesis concerning an alternative function for UCP3 (28) . In short, small amounts of neutral fatty acids are believed to be able to cross membranes by flip-flop (11), and neutral fatty acids might thus reach the mitochondrial matrix. The entry of fatty acids into the mitochondrial matrix via flip-flop might be particularly true in situations when fatty acid flux in the cells exceeds the capacity to metabolize these fatty acids and thus fatty acid concentrations inside the cells would start to increase, as can be expected to be the case in the present study. Because the fatty acids that enter the mitochondrial matrix will be deprotonated (because of the proton gradient) and because fatty acid anions are not able to flip-flop (11), we hypothesize that UCP3 might be involved in the outward translocation of fatty acid anions across the inner mitochondrial membrane. Note that, as a result, UCP3 would lower the proton gradient across the inner mitochondrial membrane, explaining the previously observed relation between UCP3 and energy metabolism (5, 7, 31, 34) . The results from the present study are compatible with this hypothesis, but further studies are necessary to examine this putative function of UCP3.
Another postulated function of UCP3 is defense against reactive oxygen species (ROS; see Ref. 33) . It has been shown that an increase in mitochondrial membrane potential results in the formation of ROS (16) . Furthermore, ROS formation is increased during and after exercise (8) . Because UCP3 decreases mitochondrial membrane potential, high levels of UCP3 during and after exercise could be helpful in the prevention of the formation of ROS. Therefore, an upregulation of UCP3 after acute exercise would be consistent with a role for UCP3 in the defense against oxidative stress. However, our finding that UCP3 is not upregulated after acute exercise in the glucose-treated condition would implicate that either UCP3 does not play a role in the defense of ROS formation or that the exercise-induced formation of ROS is lower in the glucosefed state. Indeed, high intracellular levels of fatty acids result in increased ROS formation, and it might thus be that UCP3 specifically plays a role in preventing fatty acid-induced ROS formation (18) . As stated above, we hypothesize that UCP3 is upregulated in situations when fatty acid flux into the mitochondria exceeds the capacity to metabolize these fatty acids and would thereby both reduce ROS formation and, by translocating the fatty acid anions across the mitochondrial membrane out of the matrix, prevent these fatty acids from lipid peroxidation.
In conclusion, we found that 2 h of exercise at moderate intensity had no direct effect on UCP3L mRNA expression. Abolishing the commonly observed increase in plasma FFA levels and/or fatty acid oxidation during and after exercise also prevented the upregulation of UCP3L after exercise. These results suggest that UCP3 is involved in fatty acid metabolism and is upregulated in situations when fatty acid flux into the mitochondria exceeds the capacity to metabolize these fatty acids. A possible function for UCP3 might be to reduce ROS formation and, by translocating the fatty acid anions across the mitochondrial membrane out of the matrix, prevent these fatty acids from lipid peroxidation. However, further studies are needed to test this hypothesis.
